Skip to main content
SpringerLink
Log in

Preneoplastic Lesions and Polyps of the Gastrointestinal Tract

  • Chapter
  • First Online:
Surgical Pathology of the Gastrointestinal System

  • 1806 Accesses

Abstract

The term preneoplastic lesion of the gastrointestinal (GI) tract usually conjures up an image of a polypoid lesion. While it is true that most carcinomas arise from adenomatous polyps, many other polyps occur in the GI tract which pose no risk of malignant transformation. Conversely, the preneoplastic potential is demonstrated by non-polypoid/flat lesions including flat dysplasia, inflammatory bowel disease (IBD)-associated dysplasia, and Barrett’s esophagus.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. WHO classification of tumours of the digestive system, vol. 1. 5th ed. Lyon: International Agency for Research on Cancer; 2019.

    Google Scholar 

  2. Participants in the Paris Workshop. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003;58(6 Suppl):S3–43.

    Article  Google Scholar 

  3. Takahashi T, Nosho K, Yamamoto H, Mikami M, Taniguchi H, Miyamoto N, et al. Flat-type colorectal advanced adenomas (laterally spreading tumors) have different genetic and epigenetic alterations from protruded-type advanced adenomas. Mod Pathol. 2007;20(1):139–47.

    Article  CAS  PubMed  Google Scholar 

  4. Hiraoka S, Kato J, Tatsukawa M, Harada K, Fujita H, Morikawa T, et al. Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations. Gastroenterology. 2006;131(2):379–89.

    Article  CAS  PubMed  Google Scholar 

  5. Voorham QJM, Rondagh EJA, Knol DL, van Engeland M, Carvalho B, Meijer GA, et al. Tracking the molecular features of nonpolypoid colorectal neoplasms: a systematic review and meta-analysis. Am J Gastroenterol. 2013;108(7):1042–56.

    Article  CAS  PubMed  Google Scholar 

  6. Levine JS, Ahnen DJ. Clinical practice. Adenomatous polyps of the colon. N Engl J Med. 2006;355(24):2551–7.

    Article  CAS  PubMed  Google Scholar 

  7. Cooper GS, Chak A, Koroukian S. The polyp detection rate of colonoscopy: a national study of Medicare beneficiaries. Am J Med. 2005;118(12):1413.

    Article  PubMed  Google Scholar 

  8. Kudo S, Kashida H, Tamura T, Kogure E, Imai Y, Yamano H, et al. Colonoscopic diagnosis and management of nonpolypoid early colorectal cancer. World J Surg. 2000;24(9):1081–90.

    Article  CAS  PubMed  Google Scholar 

  9. Rembacken BJ, Fujii T, Cairns A, Dixon MF, Yoshida S, Chalmers DM, et al. Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet. 2000;355(9211):1211–4.

    Article  CAS  PubMed  Google Scholar 

  10. Saitoh Y, Waxman I, West AB, Popnikolov NK, Gatalica Z, Watari J, et al. Prevalence and distinctive biologic features of flat colorectal adenomas in a North American population. Gastroenterology. 2001;120(7):1657–65.

    Article  CAS  PubMed  Google Scholar 

  11. Almadi MA, Alharbi O, Azzam N, Wadera J, Sadaf N, Aljebreen AM. Prevalence and characteristics of colonic polyps and adenomas in 2654 colonoscopies in Saudi Arabia. Saudi J Gastroenterol. 2014;20(3):154–61.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Conteduca V, Sansonno D, Russi S, Dammacco F. Precancerous colorectal lesions (review). Int J Oncol. 2013;43(4):973–84.

    Article  CAS  PubMed  Google Scholar 

  13. Adachi M, Muto T, Okinaga K, Morioka Y. Clinicopathologic features of the flat adenoma. Dis Colon Rectum. 1991;34(11):981–6.

    Article  CAS  PubMed  Google Scholar 

  14. Soetikno R, Friedland S, Kaltenbach T, Chayama K, Tanaka S. Nonpolypoid (flat and depressed) colorectal neoplasms. Gastroenterology. 2006;130(2):566–76; quiz 588–9.

    Article  PubMed  Google Scholar 

  15. Facciorusso A, Antonino M, Di Maso M, Barone M, Muscatiello N. Non-polypoid colorectal neoplasms: classification, therapy and follow-up. World J Gastroenterol. 2015;21(17):5149–57.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Hurlstone DP, Sanders DS, Cross SS, Adam I, Shorthouse AJ, Brown S, et al. Colonoscopic resection of lateral spreading tumours: a prospective analysis of endoscopic mucosal resection. Gut. 2004;53(9):1334–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zhao X, Zhan Q, Xiang L, Wang Y, Wang X, Li A, et al. Clinicopathological characteristics of laterally spreading colorectal tumor. PLoS One. 2014;9(4):e94552.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. De Maio G, Zama E, Rengucci C, Calistri D. What influences preneoplastic colorectal lesion recurrence? Oncotarget. 2017;8(7):12406–16.

    Article  PubMed  Google Scholar 

  19. Samowitz WS, Burt RL. The nonspecificity of histological findings reported for flat adenomas. Hum Pathol. 1995;26(5):571–3.

    Article  CAS  PubMed  Google Scholar 

  20. Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology. 2004;126(6):1634–48.

    Article  PubMed  Google Scholar 

  21. Harpaz N, Ward SC, Mescoli C, Itzkowitz SH, Polydorides AD. Precancerous lesions in inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2013;27(2):257–67.

    Article  CAS  PubMed  Google Scholar 

  22. Odze RD. Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological, and molecular review. Am J Gastroenterol. 1999;94(7):1746–50.

    Article  CAS  PubMed  Google Scholar 

  23. Torres C, Antonioli D, Odze RD. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients. Am J Surg Pathol. 1998;22(3):275–84.

    Article  CAS  PubMed  Google Scholar 

  24. Rubin PH, Friedman S, Harpaz N, Goldstein E, Weiser J, Schiller J, et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology. 1999;117(6):1295–300.

    Article  CAS  PubMed  Google Scholar 

  25. Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology. 1999;117(6):1288–94; discussion 1488–91.

    Article  CAS  PubMed  Google Scholar 

  26. Odze RD, Farraye FA, Hecht JL, Hornick JL. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol. 2004;2(7):534–41.

    Article  PubMed  Google Scholar 

  27. Quinn AM, Farraye FA, Naini BV, Cerda S, Coukos J, Li Y, et al. Polypectomy is adequate treatment for adenoma-like dysplastic lesions (DALMs) in Crohn’s disease. Inflamm Bowel Dis. 2013;19(6):1186–93.

    Article  PubMed  Google Scholar 

  28. Kojima M, Shimazaki H, Iwaya K, Nakamura T, Kawachi H, Ichikawa K, et al. Intramucosal colorectal carcinoma with invasion of the lamina propria: a study by the Japanese Society for Cancer of the Colon and Rectum. Hum Pathol. 2017;66:230–7.

    Article  PubMed  Google Scholar 

  29. Hurlstone DP, Cross SS, Adam I, Shorthouse AJ, Brown S, Sanders DS, et al. A prospective clinicopathological and endoscopic evaluation of flat and depressed colorectal lesions in the United Kingdom. Am J Gastroenterol. 2003;98(11):2543–9.

    Article  PubMed  Google Scholar 

  30. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326(10):658–62.

    Article  CAS  PubMed  Google Scholar 

  31. Winawer SJ, Zauber AG, O’Brien MJ, Ho MN, Gottlieb L, Sternberg SS, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med. 1993;328(13):901–6.

    Article  CAS  PubMed  Google Scholar 

  32. Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O’Brien MJ, Levin B, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006;130(6):1872–85.

    Article  PubMed  Google Scholar 

  33. Atkin W, Wooldrage K, Brenner A, Martin J, Shah U, Perera S, et al. Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study. Lancet Oncol. 2017;18(6):823–34.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Park DY, Lauwers GY. Gastric polyps: classification and management. Arch Pathol Lab Med. 2008;132(4):633–40.

    Article  PubMed  Google Scholar 

  35. Abraham SC, Park SJ, Lee J-H, Mugartegui L, Wu T-T. Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes. Mod Pathol. 2003;16(8):786–95.

    Article  PubMed  Google Scholar 

  36. Castro R, Pimentel-Nunes P, Dinis-Ribeiro M. Evaluation and management of gastric epithelial polyps. Best Pract Res Clin Gastroenterol. 2017;31(4):381–7.

    Article  CAS  PubMed  Google Scholar 

  37. Pezhouh MK, Park JY. Gastric pyloric gland adenoma. Arch Pathol Lab Med. 2015;139(6):823–6.

    Article  CAS  PubMed  Google Scholar 

  38. Shibagaki K, Fukuyama C, Mikami H, Izumi D, Yamashita N, Mishiro T, et al. Gastric foveolar-type adenomas endoscopically showing a raspberry-like appearance in the Helicobacter pylori-uninfected stomach. Endosc Int Open. 2019;7(6):E784–91.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Na HK, Cho CJ, Bae SE, Lee JH, Park YS, Ahn JY, et al. Atrophic and metaplastic progression in the background mucosa of patients with gastric adenoma. PLoS One. 2017;12(1):e0169456.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Kushima R, Vieth M, Borchard F, Stolte M, Mukaisho K, Hattori T. Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer. 2006;9(3):177–84.

    Article  PubMed  Google Scholar 

  41. Ngamruengphong S, Boardman LA, Heigh RI, Krishna M, Roberts ME, Riegert-Johnson DL. Gastric adenomas in familial adenomatous polyposis are common, but subtle, and have a benign course. Hered Cancer Clin Pract. 2014;12(1):4.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Yang MH, Son HJ, Lee JH, Kim MH, Kim JY, Kim Y-H, et al. Do we need colonoscopy in patients with gastric adenomas? The risk of colorectal adenoma in patients with gastric adenomas. Gastrointest Endosc. 2010;71(4):774–81.

    Article  PubMed  Google Scholar 

  43. Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med. 1998;339(18):1277–84.

    Article  CAS  PubMed  Google Scholar 

  44. Sakai E, Takahashi H, Kato S, Uchiyama T, Hosono K, Endo H, et al. Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm. Cancer Epidemiol Biomarkers Prev. 2011;20(9):1918–24.

    Article  PubMed  Google Scholar 

  45. Gupta AK, Pretlow TP, Schoen RE. Aberrant crypt foci: what we know and what we need to know. Clin Gastroenterol Hepatol. 2007;5(5):526–33.

    Article  PubMed  Google Scholar 

  46. Gupta B, Das P, Ghosh S, Manhas J, Sen S, Pal S, et al. Identification of high-risk aberrant crypt foci and mucin-depleted foci in the human colon with study of colon cancer stem cell markers. Clin Colorectal Cancer. 2017;16(3):204–13.

    Article  PubMed  Google Scholar 

  47. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 1987;37(2):147–51.

    Article  CAS  PubMed  Google Scholar 

  48. Inoue A, Okamoto K, Fujino Y, Nakagawa T, Muguruma N, Sannomiya K, et al. B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P. Br J Cancer. 2015;112(2):403–12.

    Article  CAS  PubMed  Google Scholar 

  49. Cheng L, Lai M-D. Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol. 2003;9(12):2642–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Roncucci L, Medline A, Bruce WR. Classification of aberrant crypt foci and microadenomas in human colon. Cancer Epidemiol Biomarkers Prev. 1991;1(1):57–60.

    CAS  PubMed  Google Scholar 

  51. Ghosh S, Gupta B, Verma P, Vishnubathla S, Pal S, Dash NR, et al. Topographic, histological and molecular study of aberrant crypt foci identified in human colon in different clinical groups. Intest Res. 2018;16(1):116–25.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Roncucci L, Pedroni M, Vaccina F, Benatti P, Marzona L, De Pol A. Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics. Cell Prolif. 2000;33(1):1–18.

    Article  CAS  PubMed  Google Scholar 

  53. Greenspan EJ, Cyr JL, Pleau DC, Levine J, Rajan TV, Rosenberg DW, et al. Microsatellite instability in aberrant crypt foci from patients without concurrent colon cancer. Carcinogenesis. 2007;28(4):769–76.

    Article  CAS  PubMed  Google Scholar 

  54. Yamashita N, Minamoto T, Ochiai A, Onda M, Esumi H. Frequent and characteristic K-ras activation in aberrant crypt foci of colon. Is there preference among K-ras mutants for malignant progression? Cancer. 1995;75(6 Suppl):1527–33.

    Article  CAS  PubMed  Google Scholar 

  55. Rosenberg DW, Yang S, Pleau DC, Greenspan EJ, Stevens RG, Rajan TV, et al. Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. Cancer Res. 2007;67(8):3551–4.

    Article  CAS  PubMed  Google Scholar 

  56. Beach R, Chan AO-O, Wu T-T, White JA, Morris JS, Lunagomez S, et al. BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol. 2005;166(4):1069–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Sottoriva A, Kang H, Ma Z, Graham TA, Salomon MP, Zhao J, et al. A Big Bang model of human colorectal tumor growth. Nat Genet. 2015;47(3):209–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW, et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110(2):223–62; quiz 263.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Bell D, Ranganathan S, Tao J, Monga SP. Novel advances in understanding of molecular pathogenesis of hepatoblastoma: a Wnt/β-catenin perspective. Gene Expr. 2017;17:141–54.

    Article  CAS  PubMed  Google Scholar 

  60. Half E, Bercovich D, Rozen P. Familial adenomatous polyposis. Orphanet J Rare Dis. 2009;4:22.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Al-Tassan N, Chmiel NH, Maynard J. Inherited variants of MYH associated with somatic G:C–>T:A mutations in colorectal tumors. Nat Genet. 2002;30:227–32.

    Article  CAS  PubMed  Google Scholar 

  62. Vogt S, Jones N, Christian D. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology. 2009;137(6):1976–85.e1–10.

    Article  CAS  PubMed  Google Scholar 

  63. Vogelstein B, Fearon ER, Hamilton S. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–32.

    Article  CAS  PubMed  Google Scholar 

  64. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–67.

    Article  CAS  PubMed  Google Scholar 

  65. Bülow S, Berk T, Neale K. The history of familial adenomatous polyposis. Familial Cancer. 2006;5(3):213–20.

    Article  PubMed  Google Scholar 

  66. Reed TE, Neel JV. A genetic study of multiple polyposis of the colon with an appendix deriving a method of estimating relative fitness. Am J Hum Genet. 1955;7:236–63.

    CAS  PubMed  PubMed Central  Google Scholar 

  67. Dinarvand P, Davaro EP, Doan JV. Familial adenomatous polyposis syndrome: an update and review of extraintestinal manifestations. Arch Pathol Lab Med. 2019;143:1382–98.

    Article  CAS  PubMed  Google Scholar 

  68. Waller A, Findeis S, Lee MJ. Familial adenomatous polyposis. J Pediatr Genet. 2016;5:78–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Hyer W, Cohen S, Attard T. Management of familial adenomatous polyposis in children and adolescents: position paper from the ESPGHAN Polyposis Working Group. J Pediatr Gastroenterol Nutr. 2019;68:428–41.

    Article  PubMed  Google Scholar 

  70. Groen EJ, Roos A, Muntinghe FL. Extra-intestinal manifestations of familial adenomatous polyposis. Ann Surg Oncol. 2008;15:2439–50.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Elkharwily A, Gottlieb K. The pancreas in familial adenomatous polyposis. JOP. 2008;9:9–18.

    PubMed  Google Scholar 

  72. Wood E, Church J, O’Malley M, LaGuardia L, Heald B, Burke C, et al. Mental health symptoms in patients with familial adenomatous polyposis: an observational study. Dis Colon Rectum. 2019;62(10):1204–11.

    Article  PubMed  Google Scholar 

  73. Shiroky JS, Lerner-Ellis JP, Govindarajan A, Urbach DR, Devon KM. Characteristics of adrenal masses in familial adenomatous polyposis. Dis Colon Rectum. 2018;61:679–85.

    Article  PubMed  Google Scholar 

  74. Chenbhanich J, Atsawarungruangkit A, Korpaisarn S, Phupitakphol T, Osataphan S, Phowthongkum P. Prevalence of thyroid diseases in familial adenomatous polyposis: a systematic review and meta-analysis. Familial Cancer. 2019;18:53–62.

    Article  CAS  PubMed  Google Scholar 

  75. Septer S, Bohaty B, Onikul R. Dental anomalies in pediatric patients with familial adenomatous polyposis. Familial Cancer. 2018;17:229–34.

    Article  PubMed  Google Scholar 

  76. Rudloff U. Gastric adenocarcinoma and proximal polyposis of the stomach: diagnosis and clinical perspectives. Clin Exp Gastroenterol. 2018;11:447–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Worthley DL, Phillips KD, Wayte N. Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut. 2012;61:774–9.

    Article  CAS  PubMed  Google Scholar 

  78. Filipe B, Baltazar C, Albuquerque C. APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas. Clin Genet. 2009;76:242–55.

    Article  CAS  PubMed  Google Scholar 

  79. Nieuwenhuis MH, Vasen HF. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol Hematol. 2007;61:153–61.

    Article  CAS  PubMed  Google Scholar 

  80. Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet. 1989;2:783–5.

    Article  CAS  PubMed  Google Scholar 

  81. Bülow S, Björk J, Christensen IJ. Duodenal adenomatosis in familial adenomatous polyposis. Gut. 2004;53:381–6.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Nielsen M, Hes FJ, Nagengast FM. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet. 2007;71:427–33.

    Article  CAS  PubMed  Google Scholar 

  83. Papp J, Kovacs ME, Matrai Z. Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary. Familial Cancer. 2016;15:85–97.

    Article  CAS  PubMed  Google Scholar 

  84. Carethers JM, Stoffel EM. Lynch syndrome and Lynch syndrome mimics: the growing complex landscape of hereditary colon cancer. World J Gastroenterol. 2015;21:9253–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Bellido F, Pineda M, Aiza G. POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance. Genet Med. 2016;18:325–32.

    Article  CAS  PubMed  Google Scholar 

  86. Müller MF, Ibrahim AEK, Arends MJ. Molecular pathological classification of colorectal cancer. Virchows Arch. 2016;469:125–34.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  87. Lynch HT, Snyder CL, Shaw TG, Heinen CD, Hitchins MP. Milestones of Lynch syndrome: 1895-2015. Nat Rev Cancer. 2015;15:181–94.

    Article  CAS  PubMed  Google Scholar 

  88. Kalady MF, Kravochuck SE, Heald B, Burke CA, Church JM. Defining the adenoma burden in Lynch syndrome. Dis Colon Rectum. 2015;58:388–92.

    Article  PubMed  Google Scholar 

  89. Yurgelun MB, Hampel H. Recent advances in Lynch syndrome: diagnosis, treatment, and cancer prevention. Am Soc Clin Oncol Educ Book. 2018;38:101–9.

    Article  PubMed  Google Scholar 

  90. Lynch HT, Smyrk T, Lynch JF. Molecular genetics and clinical-pathology features of hereditary nonpolyposis colorectal carcinoma (Lynch syndrome): historical journey from pedigree anecdote to molecular genetic confirmation. Oncology. 1998;55:103–8.

    Article  CAS  PubMed  Google Scholar 

  91. Aaltonen LA, Peltomäki P, Leach FS. Clues to the pathogenesis of familial colorectal cancer. Science. 1993;260:812–6.

    Article  CAS  PubMed  Google Scholar 

  92. Peltomäki P, Aaltonen LA, Sistonen P. Genetic mapping of a locus predisposing to human colorectal cancer. Science. 1993;260:810–2.

    Article  PubMed  Google Scholar 

  93. Vilar E, Gruber SB. Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol. 2010;7:153–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Hewish M, Lord CJ, Martin SA, Cunningham D, Ashworth A. Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nat Rev Clin Oncol. 2010;7:197–208.

    Article  PubMed  Google Scholar 

  95. Kloor M, Huth C, Voigt AY. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study. Lancet Oncol. 2012;13:598–606.

    Article  CAS  PubMed  Google Scholar 

  96. Ahadova A, von Knebel Doeberitz M, Bläker H, Kloor M. CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome. Familial Cancer. 2016;15:579–86.

    Article  CAS  PubMed  Google Scholar 

  97. Ahadova A, Gallon R, Gebert J. Three molecular pathways model colorectal carcinogenesis in Lynch syndrome. Int J Cancer. 2018;143:139–50.

    Article  CAS  PubMed  Google Scholar 

  98. Biller LH, Syngal S, Yurgelun MB. Recent advances in Lynch syndrome. Familial Cancer. 2019;18:211–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Kovacs ME, Papp J, Szentirmay Z, Otto S, Olah E. Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome. Hum Mutat. 2009;30:197–203.

    Article  CAS  PubMed  Google Scholar 

  100. Pathak SJ, Mueller JL, Okamoto K. EPCAM mutation update: variants associated with congenital tufting enteropathy and Lynch syndrome. Hum Mutat. 2019;40:142–61.

    Article  CAS  PubMed  Google Scholar 

  101. Aaltonen LA, Salovaara R, Kristo P. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 1998;338:1481–7.

    Article  CAS  PubMed  Google Scholar 

  102. Hampel H. Genetic counseling and cascade genetic testing in Lynch syndrome. Familial Cancer. 2016;15:423–7.

    Article  PubMed  Google Scholar 

  103. Rumilla K, Schowalter KV, Lindor NM. Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases. J Mol Diagn. 2011;13:93–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  104. Senter L, Clendenning M, Sotamaa K. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology. 2008;135:419–28.

    Article  CAS  PubMed  Google Scholar 

  105. Ten Broeke SW, van der Klift HM, Tops CMJ, et al. Cancer risks for PMS2-associated Lynch syndrome. J Clin Oncol. 2018;36:2961–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Møller P, Seppälä T, Bernstein I, et al. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut. 2017;66:464–72.

    Article  PubMed  Google Scholar 

  107. Goodfellow PJ, Billingsley CC, Lankes HA. Combined microsatellite instability, MLH1 methylation analysis, and immunohistochemistry for Lynch syndrome screening in endometrial cancers from GOG210: an NRG Oncology and Gynecologic Oncology Group Study. J Clin Oncol. 2015;33:4301–8.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Giardiello FM, Allen JI, Axilbund JE. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Am J Gastroenterol. 2014;109:1159–79.

    Article  PubMed  Google Scholar 

  109. Lim A, Rao P, Matin SF. Lynch syndrome and urologic malignancies: a contemporary review. Curr Opin Urol. 2019;29:357–63.

    Article  PubMed  Google Scholar 

  110. Sinicrope FA. Lynch syndrome-associated colorectal cancer. N Engl J Med. 2018;379:764–73.

    Article  CAS  PubMed  Google Scholar 

  111. Kastrinos F, Uno H, Ukaegbu C. Development and validation of the PREMM5 model for comprehensive risk assessment of Lynch syndrome. J Clin Oncol. 2017;35:2165–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Bellizzi AM, Frankel WL. Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Adv Anat Pathol. 2009;16:405–17.

    Article  CAS  PubMed  Google Scholar 

  113. Gatalica Z, Torlakovic E. Pathology of the hereditary colorectal carcinoma. Familial Cancer. 2008;7:15–26.

    Article  PubMed  Google Scholar 

  114. Musulen E, Blanco I, Carrato C. Usefulness of epithelial cell adhesion molecule expression in the algorithmic approach to Lynch syndrome identification. Hum Pathol. 2013;44:412–6.

    Article  CAS  PubMed  Google Scholar 

  115. Pearlman R, Markow M, Knight D. Two-stain immunohistochemical screening for Lynch syndrome in colorectal cancer may fail to detect mismatch repair deficiency. Mod Pathol. 2018;31:1891–900.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Gryfe R, Kim H, Hsieh ET. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000;342:69–77.

    Article  CAS  PubMed  Google Scholar 

  117. Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn. 2008;10:293–300.

    Article  PubMed  PubMed Central  Google Scholar 

  118. Stoffel EM, Mangu PB, Gruber SB. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer. European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol. 2015;33:209–17.

    Article  PubMed  Google Scholar 

  119. Berginc G, Bracko M, Ravnik-Glavac M, Glavac D. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome. Familial Cancer. 2009;8:421–9.

    Article  CAS  PubMed  Google Scholar 

  120. Barnetson RA, Tenesa A, Farrington SM. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med. 2006;354:2751–63.

    Article  CAS  PubMed  Google Scholar 

  121. Hampel H, Frankel WL, Martin E. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352:1851–60.

    Article  CAS  PubMed  Google Scholar 

  122. Hampel H, Frankel W, Panescu J. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res. 2006;66:7810–7.

    Article  CAS  PubMed  Google Scholar 

  123. Assarzadegan N, Montgomery E. What is new in 2019 World Health Organization (WHO) classification of tumors of the digestive system: review of selected updates on neuroendocrine neoplasms, appendiceal tumors, and molecular testing. Arch Pathol Lab Med. 2021;145(6):664–77.

    Article  PubMed  Google Scholar 

  124. Bettington M, Walker N, Rahman T, Vandeleur A, Whitehall V, Leggett B, et al. High prevalence of sessile serrated adenomas in contemporary outpatient colonoscopy practice. Intern Med J. 2017;47(3):318–23.

    Article  PubMed  Google Scholar 

  125. Min YW, Lee JH, Lee S-H, Park DI, Han DS, Rhee P-L, et al. Prevalence of proximal colon serrated polyps in a population at average risk undergoing screening colonoscopy: a multicenter study. Clin Res Hepatol Gastroenterol. 2012;36(6):604–8.

    Article  PubMed  Google Scholar 

  126. Ohki D, Tsuji Y, Shinozaki T, Sakaguchi Y, Minatsuki C, Kinoshita H, et al. Sessile serrated adenoma detection rate is correlated with adenoma detection rate. World J Gastrointest Oncol. 2018;10(3):82–90.

    Article  PubMed  PubMed Central  Google Scholar 

  127. Oono Y, Fu K, Nakamura H, Iriguchi Y, Yamamura A, Tomino Y, et al. Progression of a sessile serrated adenoma to an early invasive cancer within 8 months. Dig Dis Sci. 2009;54(4):906–9.

    Article  PubMed  Google Scholar 

  128. Chen S, Sun K, Chao K, Sun Y, Hong L, Weng Z, et al. Detection rate and proximal shift tendency of adenomas and serrated polyps: a retrospective study of 62,560 colonoscopies. Int J Color Dis. 2018;33(2):131–9.

    Article  Google Scholar 

  129. Liu TY, Jin DC, Khan S, Chen X, Shi T, Dong WX, et al. Clinicopathological features of advanced colorectal serrated lesions: a single-center study in China. J Dig Dis. 2018;19(4):235–41.

    Article  PubMed  Google Scholar 

  130. Castillo O, Barreda C, Recavarren S, Barriga JA, Salazar MF, Yriberry S, et al. Clinical and endoscopic features of a selected population with serrated colorectal adenomas in a private clinic in Lima – Peru. Rev Gastroenterol Peru. 2013;33(3):209–16.

    PubMed  Google Scholar 

  131. Pereyra L, Gómez EJ, González R, Fischer C, Eraña GB, Torres AG, et al. Finding sessile serrated adenomas: is it possible to identify them during conventional colonoscopy? Dig Dis Sci. 2014;59(12):3021–6.

    Article  PubMed  Google Scholar 

  132. Alatise OI, Arigbabu AO, Agbakwuru AE, Lawal OO, Sowande OA, Odujoko OO, et al. Polyp prevalence at colonoscopy among Nigerians: a prospective observational study. Niger J Clin Pract. 2014;17(6):756–62.

    Article  CAS  PubMed  Google Scholar 

  133. Parikh MP, Muthukuru S, Jobanputra Y, Naha K, Gupta NM, Wadhwa V, et al. Proximal sessile serrated adenomas are more prevalent in Caucasians, and gastroenterologists are better than nongastroenterologists at their detection. Gastroenterol Res Pract. 2017;2017:6710931.

    Article  PubMed  PubMed Central  Google Scholar 

  134. Bouwens MWE, Winkens B, Rondagh EJA, Driessen AL, Riedl RG, Masclee AAM, et al. Simple clinical risk score identifies patients with serrated polyps in routine practice. Cancer Prev Res (Phila). 2013;6(8):855–63.

    Article  Google Scholar 

  135. Teriaky A, Driman DK, Chande N. Outcomes of a 5-year follow-up of patients with sessile serrated adenomas. Scand J Gastroenterol. 2012;47(2):178–83.

    Article  PubMed  Google Scholar 

  136. He X, Wu K, Ogino S, Giovannucci EL, Chan AT, Song M. Association between risk factors for colorectal cancer and risk of serrated polyps and conventional adenomas. Gastroenterology. 2018;155(2):355–373.e18.

    Article  PubMed  Google Scholar 

  137. Yang S, Farraye FA, Mack C, Posnik O, O’Brien MJ. BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol. 2004;28(11):1452–9.

    Article  PubMed  Google Scholar 

  138. Crockett SD, Nagtegaal ID. Terminology, molecular features, epidemiology, and management of serrated colorectal neoplasia. Gastroenterology. 2019;157(4):949–966.e4.

    Article  PubMed  Google Scholar 

  139. Cassese G, Amendola A, Maione F, Giglio MC, Pagano G, Milone M, et al. Serrated lesions of the colon-rectum: a focus on new diagnostic tools and current management. Gastroenterol Res Pract. 2019;2019:9179718.

    Article  PubMed  PubMed Central  Google Scholar 

  140. Bateman AC. Pathology of serrated colorectal lesions. J Clin Pathol. 2014;67(10):865–74.

    Article  PubMed  Google Scholar 

  141. WHO Classification of Tumours Editorial Board. Digestive system tumours [Internet]. Lyon: International Agency for Research on Cancer; 2020. Available from: https://publications.iarc.fr/579.

    Google Scholar 

  142. Pai RK, Mojtahed A, Rouse RV, Soetikno RM, Kaltenbach T, Ma L, et al. Histologic and molecular analyses of colonic perineurial-like proliferations in serrated polyps: perineurial-like stromal proliferations are seen in sessile serrated adenomas. Am J Surg Pathol. 2011;35(9):1373–80.

    Article  PubMed  Google Scholar 

  143. Yang JF, Tang S-J, Lash RH, Wu R, Yang Q. Anatomic distribution of sessile serrated adenoma/polyp with and without cytologic dysplasia. Arch Pathol Lab Med. 2015;139(3):388–93.

    Article  PubMed  Google Scholar 

  144. Abdeljawad K, Vemulapalli KC, Kahi CJ, Cummings OW, Snover DC, Rex DK. Sessile serrated polyp prevalence determined by a colonoscopist with a high lesion detection rate and an experienced pathologist. Gastrointest Endosc. 2015;81(3):517–24.

    Article  PubMed  Google Scholar 

  145. Liu C, Walker NI, Leggett BA, Whitehall VL, Bettington ML, Rosty C. Sessile serrated adenomas with dysplasia: morphological patterns and correlations with MLH1 immunohistochemistry. Mod Pathol. 2017;30(12):1728–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  146. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol. 1990;14(6):524–37.

    Article  CAS  PubMed  Google Scholar 

  147. Bettington M, Walker N, Clouston A, Brown I, Leggett B, Whitehall V. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology. 2013;62(3):367–86.

    Article  PubMed  Google Scholar 

  148. Torlakovic EE, Gomez JD, Driman DK, Parfitt JR, Wang C, Benerjee T, et al. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol. 2008;32(1):21–9.

    Article  PubMed  Google Scholar 

  149. Bettington ML, Walker NI, Rosty C, Brown IS, Clouston AD, McKeone DM, et al. A clinicopathological and molecular analysis of 200 traditional serrated adenomas. Mod Pathol. 2015;28(3):414–27.

    Article  PubMed  CAS  Google Scholar 

  150. Parian A, Koh J, Limketkai BN, Eluri S, Rubin DT, Brant SR, et al. Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2016;84(1):87–95.e1.

    Article  PubMed  Google Scholar 

  151. Kilgore SP, Sigel JE, Goldblum JR. Hyperplastic-like mucosal change in Crohn’s disease: an unusual form of dysplasia? Mod Pathol. 2000;13(7):797–801.

    Article  CAS  PubMed  Google Scholar 

  152. Johnson DH, Khanna S, Smyrk TC, Loftus EV, Anderson KS, Mahoney DW, et al. Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn’s colitis. Aliment Pharmacol Ther. 2014;39(12):1408–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  153. Edelstein DL, Axilbund JE, Hylind LM, Romans K, Griffin CA, Cruz-Correa M, et al. Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut. 2013;62(3):404–8.

    Article  PubMed  Google Scholar 

  154. Carballal S, Rodríguez-Alcalde D, Moreira L, Hernández L, Rodríguez L, Rodríguez-Moranta F, et al. Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study. Gut. 2016;65(11):1829–37.

    Article  PubMed  Google Scholar 

  155. IJspeert JEG, Rana SAQ, Atkinson NSS, van Herwaarden YJ, Bastiaansen BAJ, van Leerdam ME, et al. Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis. Gut. 2017;66(2):278–84.

    Article  CAS  PubMed  Google Scholar 

  156. García-Solano J, Pérez-Guillermo M, Conesa-Zamora P, Acosta-Ortega J, Trujillo-Santos J, Cerezuela-Fuentes P, et al. Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma. Hum Pathol. 2010;41(10):1359–68.

    Article  PubMed  Google Scholar 

  157. O’Brien MJ, Yang S, Clebanoff JL, Mulcahy E, Farraye FA, Amorosino M, et al. Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol. 2004;28(4):423–34.

    Article  PubMed  Google Scholar 

  158. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. 2006;38(7):787–93.

    Article  CAS  PubMed  Google Scholar 

  159. Fennell LJ, Jamieson S, McKeone D, Corish T, Rohdmann M, Furner T, et al. MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAFV600E mutation. BMC Cancer. 2018;18(1):35.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  160. Bettington M, Walker N, Rosty C, Brown I, Clouston A, McKeone D, et al. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma. Gut. 2017;66(1):97–106.

    Article  CAS  PubMed  Google Scholar 

  161. Hashimoto T, Yamashita S, Yoshida H, Taniguchi H, Ushijima T, Yamada T, et al. WNT pathway gene mutations are associated with the presence of dysplasia in colorectal sessile serrated adenoma/polyps. Am J Surg Pathol. 2017;41(9):1188–97.

    Article  PubMed  Google Scholar 

  162. Yan HHN, Lai JCW, Ho SL, Leung WK, Law WL, Lee JFY, et al. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation. Gut. 2017;66(9):1645–56.

    Article  CAS  PubMed  Google Scholar 

  163. Murcia O, Juárez M, Rodríguez-Soler M, Hernández-Illán E, Giner-Calabuig M, Alustiza M, et al. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: prognostic implications and response to chemotherapy. PLoS One. 2018;13(9):e0203051.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  164. Kim JH, Bae JM, Cho N-Y, Kang GH. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway. Oncotarget. 2016;7(12):14095–111.

    Article  PubMed  PubMed Central  Google Scholar 

  165. Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012;107(9):1315–29; quiz 1314, 1330.

    Article  PubMed  PubMed Central  Google Scholar 

  166. Jeghers H, McKusick VA, Katz KH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med. 1949;241(25):993, illust; passim.

    Article  CAS  PubMed  Google Scholar 

  167. Giardiello FM, Trimbath JD. Peutz-Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol. 2006;4(4):408–15.

    Article  PubMed  Google Scholar 

  168. Giardiello FM, Welsh SB, Hamilton SR, Offerhaus GJ, Gittelsohn AM, Booker SV, et al. Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med. 1987;316(24):1511–4.

    Article  CAS  PubMed  Google Scholar 

  169. van Lier MGF, Westerman AM, Wagner A, Looman CWN, Wilson JHP, de Rooij FWM, et al. High cancer risk and increased mortality in patients with Peutz-Jeghers syndrome. Gut. 2011;60(2):141–7.

    Article  PubMed  Google Scholar 

  170. van Lier MGF, Wagner A, Mathus-Vliegen EMH, Kuipers EJ, Steyerberg EW, van Leerdam ME. High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol. 2010;105(6):1258–64; author reply 1265.

    Article  PubMed  Google Scholar 

  171. Latchford AR, Phillips RKS. Gastrointestinal polyps and cancer in Peutz-Jeghers syndrome: clinical aspects. Familial Cancer. 2011;10(3):455–61.

    Article  CAS  PubMed  Google Scholar 

  172. Vogel T, Schumacher V, Saleh A, Trojan J, Möslein G. Extraintestinal polyps in Peutz-Jeghers syndrome: presentation of four cases and review of the literature. Deutsche Peutz-Jeghers-Studiengruppe. Int J Colorectal Dis. 2000;15(2):118–23.

    Article  CAS  PubMed  Google Scholar 

  173. Jansen M, Ten Klooster JP, Offerhaus GJ, Clevers H. LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism. Physiol Rev. 2009;89(3):777–98.

    Article  CAS  PubMed  Google Scholar 

  174. Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet. 1999;8(8):1461–72.

    Article  CAS  PubMed  Google Scholar 

  175. Nelen MR, Kremer H, Konings IB, Schoute F, van Essen AJ, Koch R, et al. Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet. 1999;7(3):267–73.

    Article  CAS  PubMed  Google Scholar 

  176. Blumenthal GM, Dennis PA. PTEN hamartoma tumor syndromes. Eur J Hum Genet. 2008;16(11):1289–300.

    Article  CAS  PubMed  Google Scholar 

  177. Starink TM, van der Veen JP, Arwert F, de Waal LP, de Lange GG, Gille JJ, et al. The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet. 1986;29(3):222–33.

    Article  CAS  PubMed  Google Scholar 

  178. Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst. 2013;105(21):1607–16.

    Article  CAS  PubMed  Google Scholar 

  179. Shaco-Levy R, Jasperson KW, Martin K, Samadder NJ, Burt RW, Ying J, et al. Morphologic characterization of hamartomatous gastrointestinal polyps in Cowden syndrome, Peutz-Jeghers syndrome, and juvenile polyposis syndrome. Hum Pathol. 2016;49:39–48.

    Article  PubMed  Google Scholar 

  180. Riegert-Johnson DL, Gleeson FC, Roberts M, Tholen K, Youngborg L, Bullock M, et al. Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients. Hered Cancer Clin Pract. 2010;8(1):6.

    Article  PubMed  PubMed Central  Google Scholar 

  181. Syngal S, Brand RE, Church JM. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110:223–63.

    Article  PubMed  PubMed Central  Google Scholar 

  182. Schreibman IR, Baker M, Amos C, McGarrity TJ. The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol. 2005;100(2):476–90.

    Article  PubMed  Google Scholar 

  183. Gupta SK, Fitzgerald JF, Croffie JM, Chong SK, Pfefferkorn MC, Davis MM, et al. Experience with juvenile polyps in North American children: the need for pancolonoscopy. Am J Gastroenterol. 2001;96(6):1695–7.

    Article  CAS  PubMed  Google Scholar 

  184. Aretz S, Stienen D, Uhlhaas S, Stolte M, Entius MM, Loff S, et al. High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome. J Med Genet. 2007;44(11):702–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  185. Goodman ZD, Yardley JH, Milligan FD. Pathogenesis of colonic polyps in multiple juvenile polyposis: report of a case associated with gastric polyps and carcinoma of the rectum. Cancer. 1979;43(5):1906–13.

    Article  CAS  PubMed  Google Scholar 

  186. Howe JR, Mitros FA, Summers RW. The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann Surg Oncol. 1998;5(8):751–6.

    Article  CAS  PubMed  Google Scholar 

  187. Brosens LAA, van Hattem A, Hylind LM, Iacobuzio-Donahue C, Romans KE, Axilbund J, et al. Risk of colorectal cancer in juvenile polyposis. Gut. 2007;56(7):965–7.

    Article  PubMed  PubMed Central  Google Scholar 

  188. Cronkhite LW, Canada WJ. Generalized gastrointestinal polyposis; an unusual syndrome of polyposis, pigmentation, alopecia and onychotrophia. N Engl J Med. 1955;252(24):1011–5.

    Article  PubMed  Google Scholar 

  189. Takeuchi Y, Yoshikawa M, Tsukamoto N, Shiroi A, Hoshida Y, Enomoto Y, et al. Cronkhite-Canada syndrome with colon cancer, portal thrombosis, high titer of antinuclear antibodies, and membranous glomerulonephritis. J Gastroenterol. 2003;38(8):791–5.

    Article  PubMed  Google Scholar 

  190. Okamoto K, Isomoto H, Shikuwa S, Nishiyama H, Ito M, Kohno S. A case of Cronkhite-Canada syndrome: remission after treatment with anti-Helicobacter pylori regimen. Digestion. 2008;78(2–3):82–7.

    Article  PubMed  Google Scholar 

  191. Sweetser S, Ahlquist DA, Osborn NK, Sanderson SO, Smyrk TC, Chari ST, et al. Clinicopathologic features and treatment outcomes in Cronkhite-Canada syndrome: support for autoimmunity. Dig Dis Sci. 2012;57(2):496–502.

    Article  PubMed  Google Scholar 

  192. Boland BS, Bagi P, Valasek MA, Chang JT, Bustamante R, Madlensky L, et al. Cronkhite Canada syndrome: significant response to infliximab and a possible clue to pathogenesis. Am J Gastroenterol. 2016;111(5):746–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  193. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol. 2000;24(2):211–22.

    Article  CAS  PubMed  Google Scholar 

  194. Roberts F, Kirk AJ, More IA, Butler J, Reid RP. Oesophageal rhabdomyoma. J Clin Pathol. 2000;53(7):554–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  195. Kapadia SB, Meis JM, Frisman DM, Ellis GL, Heffner DK, Hyams VJ. Adult rhabdomyoma of the head and neck: a clinicopathologic and immunophenotypic study. Hum Pathol. 1993;24(6):608–17.

    Article  CAS  PubMed  Google Scholar 

  196. Balakumar R, Farr MRB, Fernando M, Jebreel A, Ray J, Sionis S. Adult-type rhabdomyoma of the larynx in Birt–Hogg–Dubé syndrome: evidence for a real association. Head Neck Pathol. 2018;13(3):507–11.

    Article  PubMed  PubMed Central  Google Scholar 

  197. Graham RP, Yasir S, Fritchie KJ, Reid MD, Greipp PT, Folpe AL. Polypoid fibroadipose tumors of the esophagus: “giant fibrovascular polyp” or liposarcoma? A clinicopathological and molecular cytogenetic study of 13 cases. Mod Pathol. 2018;31(2):337–42.

    Article  PubMed  Google Scholar 

  198. Johnston J, Helwig EB. Granular cell tumors of the gastrointestinal tract and perianal region: a study of 74 cases. Dig Dis Sci. 1981;26(9):807–16.

    Article  CAS  PubMed  Google Scholar 

  199. Pareja F, Brandes AH, Basili T, Selenica P, Geyer FC, Fan D, et al. Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors. Nat Commun. 2018;9(1):3533.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  200. Liu T-C, Lin M-T, Montgomery EA, Singhi AD. Inflammatory fibroid polyps of the gastrointestinal tract: spectrum of clinical, morphologic, and immunohistochemistry features. Am J Surg Pathol. 2013;37(4):586–92.

    Article  PubMed  Google Scholar 

  201. Huss S, Wardelmann E, Goltz D, Binot E, Hartmann W, Merkelbach-Bruse S, et al. Activating PDGFRA mutations in inflammatory fibroid polyps occur in exons 12, 14 and 18 and are associated with tumour localization. Histopathology. 2012;61(1):59–68.

    Article  PubMed  Google Scholar 

  202. Miettinen M, Makhlouf HR, Sobin LH, Lasota J. Plexiform fibromyxoma: a distinctive benign gastric antral neoplasm not to be confused with a myxoid GIST. Am J Surg Pathol. 2009;33(11):1624–32.

    Article  PubMed  Google Scholar 

  203. Spans L, Fletcher CD, Antonescu CR, Rouquette A, Coindre J-M, Sciot R, et al. Recurrent MALAT1–GLI1 oncogenic fusion and GLI1 up-regulation define a subset of plexiform fibromyxoma. J Pathol. 2016;239(3):335–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  204. Voltaggio L, Murray R, Lasota J, Miettinen M. Gastric schwannoma: a clinicopathologic study of 51 cases and critical review of the literature. Hum Pathol. 2012;43(5):650–9.

    Article  CAS  PubMed  Google Scholar 

  205. Chetty R. Reticular and microcystic schwannoma: a distinctive tumor of the gastrointestinal tract. Ann Diagn Pathol. 2011;15(3):198–201.

    Article  PubMed  Google Scholar 

  206. Miettinen M, Paal E, Lasota J, Sobin LH. Gastrointestinal glomus tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 32 cases. Am J Surg Pathol. 2002;26(3):301–11.

    Article  PubMed  Google Scholar 

  207. Mosquera J-M, Sboner A, Zhang L, Chen C-L, Sung Y-S, Chen H-W, et al. Novel MIR143-NOTCH fusions in benign and malignant glomus tumors. Genes Chromosomes Cancer. 2013;52(11):1075–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  208. Bakshi N, Rao S, Dhawan S, Singla V. Duodenal gangliocytic paraganglioma: a rare cause for gastrointestinal polyp. Indian J Pathol Microbiol. 2018;61(4):580–2.

    Article  PubMed  Google Scholar 

  209. Vignes S, Bellanger J. Primary intestinal lymphangiectasia (Waldmann’s disease). Orphanet J Rare Dis. 2008;3:5.

    Article  PubMed  PubMed Central  Google Scholar 

  210. Lawless ME, Lloyd KA, Swanson PE, Upton MP, Yeh MM. Lymphangiomatous lesions of the gastrointestinal tract: a clinicopathologic study and comparison between adults and children. Am J Clin Pathol. 2015;144(4):563–9.

    Article  CAS  PubMed  Google Scholar 

  211. Shenoy R, Rodrigues G, Gopashetty M, Kannaiyan L, Rao S. Segmental jejunal lipomatosis--a rare cause of intestinal obstruction. Yonsei Med J. 2003;44(2):359–61.

    Article  PubMed  Google Scholar 

  212. Wichendu PN, Dodiyi-Manuel A. Gastric outlet obstruction from duodenal lipoma in an adult. Niger J Surg. 2013;19(2):79–81.

    PubMed  PubMed Central  Google Scholar 

  213. Magalhães MJ, Coelho A, Salgado M, Pedroto I. A rare case of colonic pseudolipomatosis. Ann Gastroenterol. 2015;28(1):146.

    PubMed  PubMed Central  Google Scholar 

  214. Shekitka KM, Sobin LH. Ganglioneuromas of the gastrointestinal tract. Relation to Von Recklinghausen disease and other multiple tumor syndromes. Am J Surg Pathol. 1994;18(3):250–7.

    Article  CAS  PubMed  Google Scholar 

  215. Moon S-B, Park K-W, Jung S-E, Lee S-C. Vasoactive intestinal polypeptide-producing ganglioneuromatosis involving the entire colon and rectum. J Pediatr Surg. 2009;44(3):e19–21.

    Article  PubMed  Google Scholar 

  216. Grech P, Schofield JB. Spindle cell proliferations of the sigmoid colon, rectum and anus: a review with emphasis on perineurioma. Histopathology. 2020;76(3):342–53.

    Article  PubMed  Google Scholar 

  217. Gibson JA, Hornick JL. Mucosal Schwann cell “hamartoma”: clinicopathologic study of 26 neural colorectal polyps distinct from neurofibromas and mucosal neuromas. Am J Surg Pathol. 2009;33(5):781–7.

    Article  PubMed  Google Scholar 

  218. Huber AR, Agostini-Vulaj D, Drage MG, Lemmon JW. Tactile corpuscle-like bodies (Wagner-Meissner corpuscles) of the colorectum: a series of 5 cases. Int J Surg Pathol. 2017;25(8):684–7.

    Article  PubMed  Google Scholar 

  219. Lewin MR, Dilworth HP, Abu Alfa AK, Epstein JI, Montgomery E. Mucosal benign epithelioid nerve sheath tumors. Am J Surg Pathol. 2005;29(10):1310–5.

    Article  PubMed  Google Scholar 

  220. Lumb G. Pathology of ulcerative colitis. Gastroenterology. 1961;40:290–8.

    Article  CAS  PubMed  Google Scholar 

  221. Goldgraber MB. Pseudopolyps in ulcerative colitis. Dis Colon Rectum. 1965;8(5):355–63.

    Article  CAS  PubMed  Google Scholar 

  222. Lim YJ, Choi JH, Yang CH. What is the clinical relevance of filiform polyposis? Gut Liver. 2012;6(4):524–6.

    Article  PubMed  PubMed Central  Google Scholar 

  223. Hinrichs HR, Goldman H. Localized giant pseudopolyps of the colon. JAMA. 1968;205(4):248–9.

    Article  CAS  PubMed  Google Scholar 

  224. Odum BR, Bechtold ML, Diaz-Arias A. Osseous metaplasia in an inflammatory polyp of the rectum: a case report and review of the literature. Gastroenterol Res. 2012;5(2):74–8.

    Google Scholar 

  225. Oono Y, Fu K-L, Nakamura H, Iriguchi Y, Oda J, Mizutani M, et al. Bone formation in a rectal inflammatory polyp. World J Gastrointest Endosc. 2010;2(3):104–6.

    Article  PubMed  PubMed Central  Google Scholar 

  226. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14(11):931–68.

    Article  CAS  PubMed  Google Scholar 

  227. Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJW, Evans GD, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59(5):666–89.

    Article  PubMed  Google Scholar 

  228. Lobert PF, Appelman HD. Inflammatory cloacogenic polyp. A unique inflammatory lesion of the anal transitional zone. Am J Surg Pathol. 1981;5(8):761–6.

    Article  CAS  PubMed  Google Scholar 

  229. Zaman S, Mistry P, Hendrickse C, Bowley DM. Cloacogenic polyps in an adolescent: a rare cause of rectal bleeding. J Pediatr Surg. 2013;48(8):e5–7.

    Article  PubMed  Google Scholar 

  230. Nakamura S, Kino I, Akagi T. Inflammatory myoglandular polyps of the colon and rectum. A clinicopathological study of 32 pedunculated polyps, distinct from other types of polyps. Am J Surg Pathol. 1992;16:772–9.

    Article  CAS  PubMed  Google Scholar 

  231. Mitra S, Sable M, Sahoo SK, Mohanty MK. Rectal inflammatory myoglandular polyp with osseous metaplasia in a child [published online ahead of print]. Fetal Pediatr Pathol. 2020:1–5.

    Google Scholar 

  232. Griffiths AP, Hopkinson JM, Dixon MF. Inflammatory myoglandular polyp causing ileo-ileal intussusception. Histopathology. 1993;23:596–8.

    Article  CAS  PubMed  Google Scholar 

  233. Meniconi RL, Caronna R, Benedetti M. Inflammatory myoglandular polyp of the cecum: case report and review of literature. BMC Gastroenterol. 2010;10:10.

    Article  PubMed  PubMed Central  Google Scholar 

  234. Kanzaki H, Hirasaki S, Okuda M, Kudo K, Suzuki S. Lobulated inflammatory myoglandular polyp in the ascending colon observed by magnifying endoscopy and treated with endoscopic polypectomy. World J Gastroenterol. 2008;14:4838–40.

    Article  PubMed  PubMed Central  Google Scholar 

  235. Kayhan B, Küçükel F, Akdoğan M, Ozaslan E, Küçükbaş TA, Atoğlu O. Inflammatory myoglandular polyp: a rare cause of hematochezia. Turk J Gastroenterol. 2004;15:117–9.

    PubMed  Google Scholar 

  236. Harada N, Chijiiwa Y, Yao T, Koyanagi M, Ono Y, Motomura S. Inflammatory myoglandular polyp. J Clin Gastroenterol. 1999;29:104–5.

    Article  CAS  PubMed  Google Scholar 

  237. Bhardwaj K, Mohan H, Chopra R, Bhardwaj S, Sachdev A. Inflammatory myoglandular polyp of rectum. Indian J Gastroenterol. 1998;17:63–4.

    CAS  PubMed  Google Scholar 

  238. Moriyama T, Matsumoto T, Hizawa K. Inflammatory myoglandular colorectal polyps: a case series of nine patients. Endoscopy. 2003;35:363–5.

    Article  CAS  PubMed  Google Scholar 

  239. Chung SH, Son BK, Park YS. Inflammatory myoglandular polyps causing hematochezia. Gut Liver. 2010;4:146–8.

    Article  PubMed  PubMed Central  Google Scholar 

  240. Järvinen H, Nyberg M, Peltokallio P. Upper gastrointestinal tract polyps in familial adenomatosis coli. Gut. 1983;24(4):333–9.

    Article  PubMed  PubMed Central  Google Scholar 

  241. Chang C-Y, Cook MB, Lee Y-C, Lin J-T, Ando T, Bhatia S. Current status of Barrett’s esophagus research in Asia. J Gastroenterol Hepatol. 2011;26(2):240–6.

    Article  PubMed  PubMed Central  Google Scholar 

  242. Shaheen NJ, Falk GW, Iyer PG, Gerson LB. ACG clinical guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol. 2016;111(1):30–50; quiz 51.

    Article  CAS  PubMed  Google Scholar 

  243. Runge TM, Abrams JA, Shaheen NJ. Epidemiology of Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterol Clin N Am. 2015;44(2):203–31.

    Article  Google Scholar 

  244. Wani IR, Showkat HI, Bhargav DK, Samer M. Prevalence and risk factors for Barrett’s esophagus in patients with GERD in Northern India; do methylene blue-directed biopsies improve detection of Barrett’s esophagus compared the conventional method? Middle East J Dig Dis. 2014;6(4):228–36.

    PubMed  PubMed Central  Google Scholar 

  245. Sharma P, Dent J, Armstrong D, Bergman JJGHM, Gossner L, Hoshihara Y. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131(5):1392–9.

    Article  PubMed  Google Scholar 

  246. Fitzgerald RC, Pietro M, Ragunath K, Ang Y, Kang J-Y, Watson P. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7–42.

    Article  PubMed  Google Scholar 

  247. Ogiya K, Kawano T, Ito E, Nakajima Y, Kawada K, Nishikage T. Lower esophageal palisade vessels and the definition of Barrett’s esophagus. Dis Esophagus. 2008;21(7):645–9.

    Article  CAS  PubMed  Google Scholar 

  248. Grin A, Streutker CJ. Histopathology in Barrett esophagus and Barrett esophagus-related dysplasia. Clin Endosc. 2014;47(1):31–9.

    Article  PubMed  PubMed Central  Google Scholar 

  249. Clemons NJ, Koh SY, Phillips WA. Advances in understanding the pathogenesis of Barrett’s esophagus. Discov Med. 2014;17(91):7–14.

    PubMed  Google Scholar 

  250. Que J, Garman KS, Souza RF, Spechler SJ. Pathogenesis and cells of origin of Barrett’s esophagus. Gastroenterology. 2019;157(2):349–64.

    Article  PubMed  Google Scholar 

  251. Gatalica Z, Chen M, Snyder C, Mittal S, Lynch HT. Barrett’s esophagus in the patients with familial adenomatous polyposis. Fam Cancer. 2014;13(2):213–7.

    Article  CAS  PubMed  Google Scholar 

  252. Gilani SM, Montgomery E. Barrett’s esophagus: a comprehensive review and update. Diagn Histopathol. 2018;24(12):479–86.

    Article  Google Scholar 

  253. Yin F, Gonzalo DH, Lai J, Liu X. Histopathology of Barrett’s esophagus and early-stage esophageal adenocarcinoma: an updated review [Internet]. Gastrointest Disord. 2019;1:147–63. Available from: https://www.researchgate.net/publication/329224579_Histopathology_of_Barrett's_Esophagus_and_Early-Stage_Esophageal_Adenocarcinoma_An_Updated_Review.

    Article  Google Scholar 

  254. Younes M, Ertan A, Ergun G, Verm R, Bridges M, Woods K. Goblet cell mimickers in esophageal biopsies are not associated with an increased risk for dysplasia. Arch Pathol Lab Med. 2007;131(4):571–5.

    Article  PubMed  Google Scholar 

  255. Long JD, Orlando RC. Esophageal submucosal glands: structure and function. Am J Gastroenterol. 1999;94(10):2818–24.

    Article  CAS  PubMed  Google Scholar 

  256. Srivastava A, Odze RD, Lauwers GY, Redston M, Antonioli DA, Glickman JN. Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia. Am J Surg Pathol. 2007;31(11):1733–41.

    Article  PubMed  Google Scholar 

  257. Bronner MP. Barrett’s esophagus. Korean J Helicobacter Gastrointest Res. 2014;14(3):131–62.

    Article  Google Scholar 

  258. Schlemper R, Riddell R, Kato Y, Borchard F, Cooper H, Dawsey S. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47(2):251–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  259. Waters KM, Salimian KJ, Voltaggio L, Montgomery EA. Refined criteria for separating low-grade dysplasia and nondysplastic Barrett esophagus reduce equivocal diagnoses and improve prediction of patient outcome: a 10-year review. Am J Surg Pathol. 2018;42(12):1723–9.

    Article  PubMed  Google Scholar 

  260. Khan S, McDonald SAC, Wright NA, Graham TA, Odze RD, Rodriguez-Justo M. Crypt dysplasia in Barrett’s oesophagus shows clonal identity between crypt and surface cells. J Pathol. 2013;231(1):98–104.

    Article  CAS  PubMed  Google Scholar 

  261. Patil DT, Bennett AE, Mahajan D, Bronner MP. Distinguishing Barrett gastric foveolar dysplasia from reactive cardiac mucosa in gastroesophageal reflux disease. Hum Pathol. 2013;44(6):1146–53.

    Article  PubMed  Google Scholar 

  262. Patil DT, Goldblum JR, Rybicki L, Plesec TP, Mendelin JE, Bennett AE, et al. Prediction of adenocarcinoma in esophagectomy specimens based upon analysis of preresection biopsies of Barrett esophagus with at least high-grade dysplasia: a comparison of 2 systems. Am J Surg Pathol. 2012;36(1):134–41.

    Article  PubMed  Google Scholar 

  263. Endhardt K, Märkl B, Probst A, Schaller T, Aust D. Value of histomorphometric tumour thickness and smoothelin for conventional m-classification in early oesophageal adenocarcinoma. World J Gastrointest Oncol. 2017;9(11):444–51.

    Article  PubMed  PubMed Central  Google Scholar 

  264. Weston AP, Banerjee SK, Sharma P, Tran TM, Richards R, Cherian R. p53 protein overexpression in low grade dysplasia (LGD) in Barrett’s esophagus: immunohistochemical marker predictive of progression. Am J Gastroenterol. 2001;96(5):1355–62.

    Article  CAS  PubMed  Google Scholar 

  265. Younes M, Lebovitz RM, Lechago LV, Lechago J. p53 protein accumulation in Barrett’s metaplasia, dysplasia, and carcinoma: a follow-up study. Gastroenterology. 1993;105(6):1637–42.

    Article  CAS  PubMed  Google Scholar 

  266. Kinra P, Gahlot GPS, Yadav R, Baloda V, Makharia GK, Gupta SD. Histological assessment & use of immunohistochemical markers for detection of dysplasia in Barrett’s esophageal mucosa. Pathol Res Pract. 2018;214(7):993–9.

    Article  CAS  PubMed  Google Scholar 

  267. Weston BR, Helper DJ, Rex DK. Positive predictive value of endoscopic features deemed typical of gastric fundic gland polyps. J Clin Gastroenterol. 2003;36(5):399–402.

    Article  PubMed  Google Scholar 

  268. Jalving M, Koornstra JJ, Wesseling J, Boezen HM, DE Jong S, Kleibeuker JH. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther. 2006;24(9):1341–8.

    Article  CAS  PubMed  Google Scholar 

  269. Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT. Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene. Am J Pathol. 2001;158(3):1005–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  270. Sekine S, Shibata T, Yamauchi Y, Nakanishi Y, Shimoda T, Sakamoto M, et al. Beta-catenin mutations in sporadic fundic gland polyps. Virchows Arch. 2002;440(4):381–6.

    Article  CAS  PubMed  Google Scholar 

  271. Watanabe N, Seno H, Nakajima T, Yazumi S, Miyamoto S, Matsumoto S, et al. Regression of fundic gland polyps following acquisition of Helicobacter pylori. Gut. 2002;51(5):742–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  272. Goddard AF, Badreldin R, Pritchard DM, Walker MM, Warren B, British Society of Gastroenterology. The management of gastric polyps. Gut. 2010;59(9):1270–6.

    Article  PubMed  Google Scholar 

  273. Burt RW. Gastric fundic gland polyps. Gastroenterology. 2003;125(5):1462–9.

    Article  PubMed  Google Scholar 

  274. Choudhry U, Boyce HW, Coppola D. Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. Am J Clin Pathol. 1998;110(5):615–21.

    Article  CAS  PubMed  Google Scholar 

  275. Hattori T. Morphological range of hyperplastic polyps and carcinomas arising in hyperplastic polyps of the stomach. J Clin Pathol. 1985;38(6):622–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  276. Chen YS, Lin JB, Dai KS, Deng BX, Xu LZ, Lin CD, et al. Gastric xanthelasma. Chin Med J. 1989;102(8):639–43.

    CAS  PubMed  Google Scholar 

  277. Petrov S, Churtchev J, Mitova R, Boyanova L, Tarassov M. Xanthoma of the stomach--some morphometrical peculiarities and scanning electron microscopy. Hepato-Gastroenterology. 1999;46(26):1220–2.

    CAS  PubMed  Google Scholar 

  278. Kimura K, Hiramoto T, Buncher CR. Gastric xanthelasma. Arch Pathol. 1969;87(1):110–7.

    CAS  PubMed  Google Scholar 

  279. Yi SY. Dyslipidemia and H pylori in gastric xanthomatosis. World J Gastroenterol. 2007;13(34):4598–601.

    Article  PubMed  PubMed Central  Google Scholar 

  280. Moumin FA, Mohamed AA, Osman AA, Cai J. Gastric xanthoma associated with gastric cancer development: an updated review. Can J Gastroenterol Hepatol [Internet]. 2020;2020:3578927. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054765/.

    Google Scholar 

  281. Shibukawa N, Ouchi S, Wakamatsu S, Wakahara Y, Kaneko A. Gastric xanthoma is a predictive marker for early gastric cancer detected after helicobacter pylori eradication. Intern Med. 2019;58(6):779–84.

    Article  CAS  PubMed  Google Scholar 

  282. Chandan VS, Wang W. Pancreatic heterotopia in the gastric antrum. Arch Pathol Lab Med. 2004;128(1):111–2.

    Article  PubMed  Google Scholar 

  283. Gaspar Fuentes A, Campos Tarrech JM, Fernández Burgui JL, Castells Tejón E, Ruíz Rossello J, Gómez Pérez J, et al. Pancreatic ectopias. Rev Esp Enferm Apar Dig. 1973;39(3):255–68.

    CAS  PubMed  Google Scholar 

Download references

Disclaimer

The authors agree to the fact that all biopsy procedures and surgical resections were performed after taking informed consent from respective patients as per the individual Institutional policies, which also includes consent for publishing the unidentified clinical images for publication or research purposes. The authors also declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Pathology & Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India

    Suvradeep Mitra

  2. Al Salam International Hospital, Kuwait City, Kuwait

    Rajaguru Paramaguru

  3. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

    Prasenjit Das

  4. Columbia Asia Hospital, Whitefield, Bangalore, Karnataka, India

    Sanjeev Vasudev Katti

Authors
  1. Suvradeep Mitra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rajaguru Paramaguru
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prasenjit Das
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sanjeev Vasudev Katti
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

    Prasenjit Das

  2. Department of Pathology, Al Sabah Hospital, Kuwait City, Kuwait

    Kaushik Majumdar

  3. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

    Siddhartha Datta Gupta

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mitra, S., Paramaguru, R., Das, P., Katti, S.V. (2022). Preneoplastic Lesions and Polyps of the Gastrointestinal Tract. In: Das, P., Majumdar, K., Datta Gupta, S. (eds) Surgical Pathology of the Gastrointestinal System. Springer, Singapore. https://doi.org/10.1007/978-981-16-6395-6_16

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-6395-6_16

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-6394-9

  • Online ISBN: 978-981-16-6395-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation